A novel role for inhibitor of apoptosis (IAP) proteins as regulators of endothelial barrier function by mediating RhoA activation

FASEB Journal

Volumn 28, Issue 4, 2014, Pages 1938-1946

  Hornburger, Michael C ^a,b   Mayer, Bettina A ^b   Leonhardt, Stefanie ^b   Willer, Elisabeth A ^b   Zahler, Stefan ^b   Beyerle, Andrea ^a   Rajalingam, Krishnaraj ^a   Vollmar, Angelika M ^b   Fürst, Robert ^a  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Inflammation; Permeability; Small RhoA GTPases

Indexed keywords

ANTINEOPLASTIC AGENT; INHIBITOR OF APOPTOSIS PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MYOSIN LIGHT CHAIN 2; PROTEIN KINASE C; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; THROMBIN; THROMBIN RECEPTOR ACTIVATING PEPTIDE; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; CALCIUM SIGNALING; CANCER CELL; CELL FUNCTION; CELL JUNCTION; CELL MEMBRANE PERMEABILITY; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; ELECTRIC RESISTANCE; ENDOTHELIAL BARRIER FUNCTION; ENDOTHELIUM CELL; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYPOTHESIS; IMMUNOCYTOCHEMISTRY; IMMUNOPRECIPITATION; PRIORITY JOURNAL; STRESS FIBER; TRANSENDOTHELIAL ELECTRICAL RESISTANCE; UBIQUITINATION; WESTERN BLOTTING;

INFLAMMATION; PERMEABILITY; SMALL RHOA GTPASES;

ADHERENS JUNCTIONS; BLOTTING, WESTERN; CALCIUM; CELL MEMBRANE PERMEABILITY; CELLS, CULTURED; ELECTRIC IMPEDANCE; ENZYME ACTIVATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MICROSCOPY, CONFOCAL; MUTATION; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; PROTEIN BINDING; RHOA GTP-BINDING PROTEIN; RNA INTERFERENCE; STRESS FIBERS; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 84901047438     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.13-235754     Document Type: Article

References (33)

1. Fulda, S., and Vucic, D. (2012) Targeting IAP proteins for therapeutic intervention in cancer. Nat. Rev. Drug Disc. 11, 109-124
2. Srinivasula, S. M., and Ashwell, J. D. (2008) IAPs: what's in a name? Mol. Cell 30, 123-135
3. Mayer, B. A., Rehberg, M., Erhardt, A., Wolf, A., Reichel, C. A., Kracht, M., Krombach, F., Tiegs, G., Zahler, S., Vollmar, A. M., and Furst, R. (2011) Inhibitor of apoptosis proteins as novel targets in inflammatory processes. Arterioscler. Thromb. Vasc. Biol. 31, 2240-2250
4. Varfolomeev, E., Goncharov, T., Maecker, H., Zobel, K., Komuves, L. G., Deshayes, K., and Vucic, D. (2012) Cellular inhibitors of apoptosis are global regulators of NF-kappaB and MAPK activation by members of the TNF family of receptors. Sci. Signal. 5, ra22
5. Kearney, C. J., Sheridan, C., Cullen, S. P., Tynan, G. A., Logue, S. E., Afonina, I. S., Vucic, D., Lavelle, E. C., and Martin, S. J. (2013) Inhibitor of apoptosis proteins (IAPs) and their antagonists regulate spontaneous and tumor necrosis factor (TNF)-induced proinflammatory cytokine and chemokine production. J. Biol. Chem. 288, 4878-4890
6. Medzhitov, R. (2008) Origin and physiological roles of inflammation. Nature 454, 428-435
7. Foley, J. F. (2013) Focus issue: understanding mechanisms of inflammation. Sci. Signal. 6, eg2
8. Kumar, P., Shen, Q., Pivetti, C. D., Lee, E. S., Wu, M. H., and Yuan, S. Y. (2009) Molecular mechanisms of endothelial hyperpermeability: implications in inflammation. Exp. Rev. Mol. Med. 11, e19
9. Vandenbroucke, E., Mehta, D., Minshall, R., and Malik, A. B. (2008) Regulation of endothelial junctional permeability. Ann. N. Y. Acad. Sci. 1123, 134-145
10. Oost, T. K., Sun, C., Armstrong, R. C., Al-Assaad, A. S., Betz, S. F., Deckwerth, T. L., Ding, H., Elmore, S. W., Meadows, R. P., Olejniczak, E. T., Oleksijew, A., Oltersdorf, T., Rosenberg, S. H., Shoemaker, A. R., Tomaselli, K. J., Zou, H., and Fesik, S. W. (2004) Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer. J. Med. Chem. 47, 4417-4426
11. Ades, E. W., Candal, F. J., Swerlick, R. A., George, V. G., Summers, S., Bosse, D. C., and Lawley, T. J. (1992) HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J. Invest. Dermatol. 99, 683-690
12. Bubik, M. F., Willer, E. A., Bihari, P., Jurgenliemk, G., Ammer, H., Krombach, F., Zahler, S., Vollmar, A. M., and Furst, R. (2012) A novel approach to prevent endothelial hyperpermeability: the Crataegus extract WS(R) 1442 targets the cAMP/Rap1 pathway. J. Mol. Cell. Cardiol. 52, 196-205
13. Furst, R., Bubik, M. F., Bihari, P., Mayer, B. A., Khandoga, A. G., Hoffmann, F., Rehberg, M., Krombach, F., Zahler, S., and Vollmar, A. M. (2008) Atrial natriuretic peptide protects against histamine-induced endothelial barrier dysfunction in vivo. Mol. Pharmacol. 74, 1-8
14. Willer, E. A., Malli, R., Bondarenko, A. I., Zahler, S., Vollmar, A. M., Graier, W. F., and Furst, R. (2012) The vascular barrierprotecting hawthorn extract WS(R) 1442 raises endothelial calcium levels by inhibition of SERCA and activation of the IP3 pathway. J. Mol. Cell. Cardiol. 53, 567-577
15. Oberoi, T. K., Dogan, T., Hocking, J. C., Scholz, R. P., Mooz, J., Anderson, C. L., Karreman, C., Meyer zu Heringdorf, D., Schmidt, G., Ruonala, M., Namikawa, K., Harms, G. S., Carpy, A., Macek, B., Koster, R. W., and Rajalingam, K. (2012) IAPs regulate the plasticity of cell migration by directly targeting Rac1 for degradation. EMBO J. 31, 14-28
16. Lampugnani, M. G., and Dejana, E. (2007) Adherens junctions in endothelial cells regulate vessel maintenance and angiogenesis. Thromb. Res. 120(Suppl. 2), S1-S6
17. Shen, Q., Rigor, R. R., Pivetti, C. D., Wu, M. H., and Yuan, S. Y. (2010) Myosin light chain kinase in microvascular endothelial barrier function. Cardiovasc. Res. 87, 272-280
18. Kim, K. M., Csortos, C., Czikora, I., Fulton, D., Umapathy, N. S., Olah, G., and Verin, A. D. (2012) Molecular characterization of myosin phosphatase in endothelium. J. Cell. Physiol. 227, 1701-1708
19. Wang, C. Y., Mayo, M. W., Korneluk, R. G., Goeddel, D. V., and Baldwin, A. S., Jr. (1998) NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281, 1680-1683
20. Feltham, R., Bettjeman, B., Budhidarmo, R., Mace, P. D., Shirley, S., Condon, S. M., Chunduru, S. K., McKinlay, M. A., Vaux, D. L., Silke, J., and Day, C. L. (2011) Smac mimetics activate the E3 ligase activity of cIAP1 protein by promoting RING domain dimerization. J. Biol. Chem. 286, 17015-17028
21. Nakatani, Y., Kleffmann, T., Linke, K., Condon, S. M., Hinds, M. G., and Day, C. L. (2013) Regulation of ubiquitin transfer by XIAP, a dimeric RING E3 ligase. Biochem. J. 450, 629-638
22. Vandenabeele, P., and Bertrand, M. J. (2012) The role of the IAP E3 ubiquitin ligases in regulating pattern-recognition receptor signalling. Nat. Rev. Immunol. 12, 833-844
23. Gyrd-Hansen, M., and Meier, P. (2010) IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer. Nat. Rev. Cancer 10, 561-574
24. Sanna, M. G., da Silva Correia, J., Ducrey, O., Lee, J., Nomoto, K., Schrantz, N., Deveraux, Q. L., and Ulevitch, R. J. (2002) IAP suppression of apoptosis involves distinct mechanisms: the TAK1/JNK1 signaling cascade and caspase inhibition. Mol. Cell. Biol. 22, 1754-1766
25. Kipnis, E., Guery, B. P., Tournoys, A., Leroy, X., Robriquet, L., Fialdes, P., Neviere, R., and Fourrier, F. (2004) Massive alveolar thrombin activation in Pseudomonas aeruginosa-induced acute lung injury. Shock 21, 444-451
26. Welty-Wolf, K. E., Carraway, M. S., Ortel, T. L., and Piantadosi, C. A. (2002) Coagulation and inflammation in acute lung injury. J. Thromb. Haemost. 88, 17-25
27. Minami, T., Sugiyama, A., Wu, S. Q., Abid, R., Kodama, T., and Aird, W. C. (2004) Thrombin and phenotypic modulation of the endothelium. Arterioscler. Thromb. Vasc. Biol. 24, 41-53
28. van Nieuw Amerongen, G. P., Draijer, R., Vermeer, M. A., and van Hinsbergh, V. W. (1998) Transient and prolonged increase in endothelial permeability induced by histamine and thrombin: role of protein kinases, calcium, and RhoA. Circ. Res. 83, 1115-1123
29. Damgaard, R. B., Fiil, B. K., Speckmann, C., Yabal, M., zur Stadt, U., Bekker-Jensen, S., Jost, P. J., Ehl, S., Mailand, N., and Gyrd-Hansen, M. (2013) Disease-causing mutations in the XIAP BIR2 domain impair NOD2-dependent immune signalling. EMBO Mol. Med. 5, 1278-1295
30. Oberoi-Khanuja, T. K., and Rajalingam, K. (2012) IAPs as E3 ligases of Rac1: shaping the move. Small GTPases 3, 131-136
31. Geisbrecht, E. R., and Montell, D. J. (2004) A role for Drosophila IAP1-mediated caspase inhibition in Rac-dependent cell migration. Cell 118, 111-125
32. Sahai, E., Garcia-Medina, R., Pouyssegur, J., and Vial, E. (2007) Smurf1 regulates tumor cell plasticity and motility through degradation of RhoA leading to localized inhibition of contractility. J. Cell Biol. 176, 35-42
33. Liu, J., Zhang, D., Luo, W., Yu, Y., Yu, J., Li, J., Zhang, X., Zhang, B., Chen, J., Wu, X. R., Rosas-Acosta, G., and Huang, C. (2011) X-linked inhibitor of apoptosis protein (XIAP) mediates cancer cell motility via Rho GDP dissociation inhibitor (RhoGDI)-dependent regulation of the cytoskeleton. J. Biol. Chem. 286, 15630-15640